DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Reyataz (Atazanavir) - Serious Reactions - Suspected Cause - Side Effect Reports

 
 



Index of reports > Serious Reactions (402)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Reyataz (Atazanavir) serious reactions. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 402   Next >>

Possible Reyataz side effects in 31 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient: 31 year old female

Reactions: Abortion Spontaneous

Drug(s) suspected as cause:
Norvir
    Dosage: 100 mg/day taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-08-17

Reyataz
    Dosage: 300 mg/day taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-08-17

Truvada
    Dosage: 1 tab/caps daily taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-08-17



Possible Reyataz side effects in 36 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient: 36 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Epivir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiviral Treatment

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy

Viread
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy



Possible Reyataz side effects in 36 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: 36 year old female

Reactions: Abortion Induced

Drug(s) suspected as cause:
Epivir
    Administration route: Oral
    Indication: Antiretroviral Therapy

Norvir
    Dosage: daily
    Administration route: Oral
    Indication: Antiretroviral Therapy

Reyataz
    Administration route: Oral
    Indication: Antiretroviral Therapy

Viread
    Administration route: Oral
    Indication: Antiretroviral Therapy



Possible Reyataz side effects in 66 year old male

Reported by a physician from Japan on 2012-08-24

Patient: 66 year old male

Reactions: Glomerulonephritis Chronic

Drug(s) suspected as cause:
Epzicom
    Dosage: 1df: 1tab
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-06-27

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-09-15

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-09-15

Other drugs received by patient: Depakene



Possible Reyataz side effects in

Reported by a physician from United States on 2012-08-23

Patient: , weighing 1.9 kg (4.2 pounds)

Reactions: Foetal Exposure During Pregnancy, Congenital Foot Malformation

Drug(s) suspected as cause:
Combivir
    Dosage: 2tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Norvir
    Dosage: 100mgd per day
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Raltegravir
    Dosage: 800mgd per day
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Reyataz
    Dosage: 300mgd per day
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Truvada
    Dosage: 1tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27



Possible Reyataz side effects in 26 year old female

Reported by a physician from United States on 2012-08-23

Patient: 26 year old female

Reactions: Prenatal Screening Test Abnormal, Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Combivir
    Dosage: 2tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Raltegravir
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Truvada
    Dosage: 1tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27



Possible Reyataz side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21

Patient: female

Reactions: Amniotic Fluid Volume Decreased, Abortion Spontaneous

Drug(s) suspected as cause:
Norvir
    Dosage: taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-01-24

Reyataz
    Dosage: taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-01-24

Truvada
    Dosage: taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-01-24



Possible Reyataz side effects in female

Reported by a physician from France on 2012-08-17

Patient: female

Reactions: Foetal Exposure During Pregnancy, Congenital Central Nervous System Anomaly, Abortion Induced, Congenital Absence of Cranial Vault

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient:

Reactions: Foetal Exposure During Pregnancy, Congenital Anomaly, Abortion Spontaneous

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient: male, weighing 3.7 kg (8.2 pounds)

Reactions: Hydronephrosis, Foetal Exposure During Pregnancy, Congenital Megaureter, Pyelocaliectasis

Drug(s) suspected as cause:
Combivir
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Retrovir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in female

Reported by a physician from France on 2012-08-16

Patient: female

Reactions: Oligohydramnios, Abortion Induced, Pregnancy

Drug(s) suspected as cause:
Norvir
    Dosage: 1 film coated tablet daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-01-24

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-01-24

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-01-24



Possible Reyataz side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-15

Patient: female

Reactions: Abortion Spontaneous

Drug(s) suspected as cause:
Emtricitabine / Tenofovir Disoproxil Fumarate
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-08-17

Reyataz
    Dosage: 300 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-08-17

Ritonavir
    Dosage: 100 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-08-17



Possible Reyataz side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-14

Patient: male

Reactions: T-Lymphocyte Count Decreased

Drug(s) suspected as cause:
Reyataz

Zerit

Other drugs received by patient: Lovaza; Fish OIL; Vitamin D; Vitamin A Palmitate



Possible Reyataz side effects in female

Reported by a physician from France on 2012-08-14

Patient: female

Reactions: Weight Increased, Liver Disorder

Drug(s) suspected as cause:
Norvir
    Indication: HIV Infection
    Start date: 2008-04-01
    End date: 2009-06-01

Norvir
    Administration route: Oral
    Start date: 2011-08-22
    End date: 2012-04-13

Reyataz
    Administration route: Oral
    Start date: 2011-08-22
    End date: 2012-03-13

Reyataz
    Indication: HIV Infection
    Start date: 2008-08-01
    End date: 2009-06-01

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-04-14



Possible Reyataz side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14

Patient: female

Reactions: Amniotic Fluid Volume Decreased, Abortion Spontaneous

Drug(s) suspected as cause:
Norvir
    Dosage: taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-01-24

Reyataz
    Dosage: taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-01-24

Truvada
    Dosage: taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-01-24



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14

Patient:

Reactions: Cytogenetic Abnormality, Premature Baby, Foetal Exposure During Pregnancy, Hypoxia, Limb Malformation, Cerebral Haemorrhage, Genetic Polymorphism

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14

Patient: female

Reactions: Abortion Spontaneous

Drug(s) suspected as cause:
Norvir
    Dosage: 100 mg/day taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-08-17

Reyataz
    Dosage: 300 mg/day taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-08-17

Truvada
    Dosage: 1 tab/caps daily taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-08-17



Possible Reyataz side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-14

Patient: female

Reactions: Weight Increased

Drug(s) suspected as cause:
Norvir
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-08-22
    End date: 2012-03-13

Reyataz
    Dosage: 2 df, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-08-22
    End date: 2012-03-13

Truvada
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-04-14



Possible Reyataz side effects in 39 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14

Patient: 39 year old female

Reactions: Foetal Death, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Norvir
    Dosage: not taken at conception
    Administration route: Oral
    Start date: 2011-07-01

Norvir
    Dosage: taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-07-01
    End date: 2011-05-20

Reyataz
    Dosage: taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-07-01
    End date: 2011-05-20

Reyataz
    Dosage: not taken at conception
    Administration route: Oral
    Start date: 2011-07-01

Truvada
    Dosage: 1 tab/caps not taken at conception
    Administration route: Oral
    Start date: 2011-07-01

Truvada
    Dosage: 1 tab/caps taken at conception
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-07-01
    End date: 2011-05-20

Other drugs received by patient: Aldomet; Labetalol HCL



Possible Reyataz side effects in 57 year old female

Reported by a physician from United States on 2012-08-10

Patient: 57 year old female

Reactions: Chronic Obstructive Pulmonary Disease, Myocardial Infarction, Arrhythmia

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz



Possible Reyataz side effects in 30 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient: 30 year old female

Reactions: Abortion Induced

Drug(s) suspected as cause:
Norvir
    Administration route: Oral
    Indication: Antiviral Treatment

Reyataz
    Administration route: Oral
    Indication: Antiviral Treatment

Truvada
    Administration route: Oral
    Indication: Antiviral Treatment



Possible Reyataz side effects in 30 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-08

Patient: 30 year old female

Reactions: Stillbirth, Maternal Exposure During Pregnancy

Drug(s) suspected as cause:
Epzicom
    Dosage: 1tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2010-05-01

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiviral Treatment
    Start date: 2011-05-01

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiviral Treatment
    Start date: 2010-05-01



Possible Reyataz side effects in 40 year old female

Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-08-08

Patient: 40 year old female

Reactions: Premature Rupture of Membranes, Premature Baby, Maternal Exposure During Pregnancy, PRE-Eclampsia

Drug(s) suspected as cause:
Epivir
    Dosage: 600mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-03-22

Intelence
    Dosage: 400mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-04-19
    End date: 2011-06-14

Kaletra
    Dosage: 4tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-06-16

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-04-04
    End date: 2011-04-18

Retrovir
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-06-16

Reyataz
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-04-19
    End date: 2011-06-16

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Start date: 2011-04-04
    End date: 2011-04-18



Possible Reyataz side effects in 44 year old female

Reported by a pharmacist from United Kingdom on 2012-08-08

Patient: 44 year old female

Reactions: Dysphagia, Cerebrovascular Accident

Drug(s) suspected as cause:
Reyataz



Possible Reyataz side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-08

Patient: female

Reactions: Genital Labial Adhesions

Drug(s) suspected as cause:
Norvir

Prezista

Reyataz

Truvada



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-07

Patient: , weighing 1.9 kg (4.2 pounds)

Reactions: Foetal Exposure During Pregnancy, Congenital Foot Malformation

Drug(s) suspected as cause:
Combivir
    Dosage: 2tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Norvir
    Dosage: 100mgd per day
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Raltegravir
    Dosage: 800mgd per day
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Reyataz
    Dosage: 300mgd per day
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Truvada
    Dosage: 1tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27



Possible Reyataz side effects in 66 year old female

Reported by a physician from Germany on 2012-08-07

Patient: 66 year old female, weighing 60.0 kg (132.0 pounds)

Reactions: Rhabdomyolysis, Drug Interaction

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Reyataz

Other drugs received by patient possibly interacting with the suspect drug:
Simvastatin
    Dosage: for about 10 days
    Administration route: Oral
    Indication: Coronary Artery Disease



Possible Reyataz side effects in 26 year old female

Reported by a physician from United States on 2012-08-07

Patient: 26 year old female

Reactions: Prenatal Screening Test Abnormal, Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Combivir
    Dosage: 2tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Raltegravir
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Truvada
    Dosage: 1tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27



Possible Reyataz side effects in female

Reported by a physician from France on 2012-08-06

Patient: female

Reactions: Oligohydramnios, Abortion Induced, Pregnancy

Drug(s) suspected as cause:
Norvir
    Dosage: 1 film coated tablet daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-01-24

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-01-24

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-01-24



Possible Reyataz side effects in female

Reported by a pharmacist from Canada on 2012-08-03

Patient: female

Reactions: Microcephaly, Foetal Exposure During Pregnancy, Infantile Spasms

Drug(s) suspected as cause:
Norvir
    Indication: Product Used FOR Unknown Indication

Reyataz
    Indication: Product Used FOR Unknown Indication

Truvada
    Indication: Product Used FOR Unknown Indication



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014